Ascentage Pharma Group International American Depository Shares (AAPG) vs Nektar Therapeutics (NKTR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Nektar Therapeutics (NKTR) has outperformed Ascentage Pharma Group International American Depository Shares (AAPG) over the past year, losing 44.4% versus a loss of 60.9%. Ascentage Pharma Group International American Depository Shares is the larger company by market cap ($1.12 billion vs $1.03 billion), about 1.1 times the size. Ascentage Pharma Group International American Depository Shares converts more of its revenue into profit, with a net margin of -41.3% versus -297.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AAPG | NKTR |
|---|---|---|
| Share price | $11.97 | $30.20 |
| Market cap | $1.12B | $1.03B |
| 1-day change | -3.78% | -7.19% |
| YTD return | -54.38% | -28.57% |
| 1-year return | -60.93% | -44.36% |
| 5-year return | — | -82.04% |
| EPS (TTM) | $-2.26 | $-22.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $134.35M | $55.23M |
| Revenue growth (YoY) | — | -43.89% |
| Net income (latest FY) | $-55.54M | $-164.08M |
| Gross margin | 97.03% | 100.00% |
| Operating margin | — | -253.66% |
| Net margin | -41.34% | -297.07% |
| 52-week high | $33.09 | $109.00 |
| 52-week low | $11.97 | $30.13 |
| Distance from 52-week high | -63.83% | -72.29% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +271.76% | +336.82% |
| Average volume | 6.97K | 1.12M |
| Shares outstanding | 93.33M | 34.21M |
| Employees | 828 | 63 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NKTR has outperformed AAPG by 16.6 percentage points over the past year.
- Ascentage Pharma Group International American Depository Shares is more profitable, keeping -41.3 cents of every revenue dollar as net income versus -297.1 cents for Nektar Therapeutics.
About Ascentage Pharma Group International American Depository Shares
AAPG stock →Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation.
Health Care · Biotechnology: Pharmaceutical Preparations · 828 employees
About Nektar Therapeutics
NKTR stock →Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma.
Health Care · Biotechnology: Pharmaceutical Preparations · 63 employees
AAPG vs NKTR FAQ
Which is bigger, Ascentage Pharma Group International American Depository Shares or Nektar Therapeutics?
Ascentage Pharma Group International American Depository Shares (AAPG) is larger, with a market capitalization of $1.12B compared with $1.03B for Nektar Therapeutics (NKTR).
Which stock has performed better over the past year, AAPG or NKTR?
NKTR returned -44.36% over the past 12 months, compared with -60.93% for AAPG (price return, excluding dividends). Past performance does not predict future results.
Are Ascentage Pharma Group International American Depository Shares and Nektar Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.